Abstract
Recently discovered mutations in 2 genes, BRCA1 and BRCA2, account for most hereditary cases of breast cancer. Individuals with mutations in either BRCA1 or BRCA2 carry an elevated lifetime risk of breast or ovarian cancer. Genetic testing for these mutations now allows individuals to learn if they are at heightened cancer risk. This genetic testing may have entered the health care system without the development of adequate notification protocols. This paper reviews the psychological and behavioral sequelae of being at increased risk for breast or ovarian cancer due to personal or family history. Similar issues relating to the BRCA1 and BRCA2 genetic screening and the notification process also are discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.